Murphy Middleton Hinkle & Parker’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,755
Closed -$233K 212
2025
Q3
$233K Buy
4,755
+2
+0% +$102 0.11% 129
2025
Q2
$222K Hold
4,753
0.12% 124
2025
Q1
$222K Hold
4,753
0.12% 124
2024
Q4
$243K Buy
4,753
+1
+0% +$52 0.14% 121
2024
Q3
$211K Buy
+4,752
New +$208K 0.11% 131
2022
Q2
Sell
-4,293
Closed -$210K 143
2022
Q1
$210K Buy
4,293
+1
+0% +$51 0.11% 142
2021
Q4
$205K Buy
+4,292
New +$203K 0.11% 143
2020
Q1
Sell
-6,028
Closed -$236K 130
2019
Q4
$236K Buy
+6,028
New +$221K 0.16% 120

Other funds holding SNV

Murphy Middleton Hinkle & Parker's SNV Position: Q4 2025 in Review

Murphy Middleton Hinkle & Parker sold out of Synovus (SNV) in Q4 2025, closing a stake of 4,755 shares — an estimated $233K sold.

Murphy Middleton Hinkle & Parker first reported a position in SNV in Q4 2019 and held it in 8 quarters. The position peaked at $243K in Q4 2024. 452 funds tracked by Wall St. Rank hold SNV as of Q4 2025.

  • Murphy Middleton Hinkle & Parker reported no remaining Synovus position as of Q4 2025 after selling out during the quarter.
  • Murphy Middleton Hinkle & Parker sold 4,755 Synovus shares in Q4 2025, an estimated $233K.
  • Murphy Middleton Hinkle & Parker first reported a position in Synovus in Q4 2019 and held it in 8 quarters.
  • Murphy Middleton Hinkle & Parker's Synovus position peaked at $243K in Q4 2024.
  • 452 funds tracked by Wall St. Rank held Synovus as of Q4 2025.

Based on Murphy Middleton Hinkle & Parker's 13F filing for Q4 2025, filed 9 Jan 2026.